Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics Post author:Sam Post published:December 3, 2017 Post category:BioPharma The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics. Source: BioSpace You Might Also Like Lilly Exploring Strategic Alternatives for Animal Health Biz January 31, 2018 Another Drug Bites the Dust: Merck & Co. Stops Late-Stage Alzheimer???s Study February 14, 2017 Infinity Pharma And Bristol-Myers Squibb Expand Clinical Collaboration Evaluating IPI-549 In Combination With Opdivo (Nivolumab) September 24, 2017
Infinity Pharma And Bristol-Myers Squibb Expand Clinical Collaboration Evaluating IPI-549 In Combination With Opdivo (Nivolumab) September 24, 2017